Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination

被引:335
|
作者
Storch, MK
Piddlesden, S
Haltia, M
Iivanainen, M
Morgan, P
Lassmann, H
机构
[1] Univ Vienna, Inst Neurol, A-1090 Vienna, Austria
[2] Univ Wales Coll Med, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales
[3] Univ Helsinki, Dept Pathol, Helsinki, Finland
[4] Univ Helsinki, Dept Child Neurol, Helsinki, Finland
关键词
D O I
10.1002/ana.410430409
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination. This was particularly evident for the C9neo antigen, which is a marker for the activated lyric complement complex and was exclusively deposited in the areas of active myelin destruction. In addition, macrophages in the lesions contained degradation products that were immunoreactive for myelin antigens, immunoglobulins, and C9neo antigen. Destruction of myelin sheaths was associated with incomplete loss of oligodendrocytes in the active areas and reappearance of oligodendrocytes with remyelination in the inactive plaque center.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 50 条
  • [31] DEMONSTRATION OF FLUORESCENT X AND Y BODIES AFTER ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED CYTOTOXICITY
    SHALEV, A
    BERCZI, I
    HAMERTON, JL
    IMMUNOGENETICS, 1977, 5 (05) : 405 - 414
  • [32] ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED JUNCTIONS BETWEEN SCHISTOSOMA-MANSONI AND POLYMORPHONUCLEAR LEUKOCYTES
    CAULFIELD, JP
    BUTTERWORTH, AE
    KORMAN, G
    DAVID, JR
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 908 - 908
  • [33] IMMUNOSYMPATHECTOMY - LACK OF EVIDENCE FOR A COMPLEMENT-MEDIATED CYTO-TOXIC MECHANISM
    GOEDERT, M
    OTTEN, U
    SCHAFER, T
    SCHWAB, M
    THOENEN, H
    BRAIN RESEARCH, 1980, 201 (02) : 399 - 409
  • [34] IMMUNE DAMAGE TO THE MESANGIUM - ANTIBODY-MEDIATED AND COMPLEMENT-MEDIATED STIMULATION AND DESTRUCTION OF MESANGIAL CELLS
    HANSCH, GM
    SCHIEREN, G
    WAGNER, C
    SCHONERMARK, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 2 (10): : S139 - S143
  • [35] ANTIBODY AVIDITY AND COMPLEMENT-MEDIATED SOLUBILIZATION OF PRECIPITATES DURING THE IMMUNE-RESPONSE
    STASSEN, FL
    BEEK, CJ
    IMMUNOLOGY, 1982, 46 (02) : 289 - 295
  • [36] MEMBRANE EVENTS DURING HUMAN-ANTIBODY AND COMPLEMENT-MEDIATED PLATELET INJURY
    SHATTIL, SJ
    CINES, DB
    SCHREIBER, AD
    CLINICAL RESEARCH, 1977, 25 (03): : A347 - A347
  • [37] ANTIBODY AND COMPLEMENT-MEDIATED UPTAKE OF HIV-1 BY HUMAN MONOCYTES AND GRANULOCYTES
    BAKKER, LJ
    NOTTET, HS
    DEVOS, NM
    VANSTRIJP, JAG
    VISSER, MR
    VERHOEF, J
    CLINICAL RESEARCH, 1990, 38 (02): : A461 - A461
  • [38] ANTIBODY AND COMPLEMENT-MEDIATED ADHERENCE OF FELINE LEUKOCYTES TO THE SURFACE OF BRUGIA-PAHANGI
    JOHNSON, P
    MACKENZIE, C
    SUSWILLO, R
    DENHAM, D
    PARASITOLOGY, 1980, 81 (OCT) : R36 - R36
  • [39] Mechanisms underlying induction of antibody-mediated demyelination in muliple sclerosis
    Berg, Carsten Tue
    Khorooshi, Reza M. H.
    Asgari, Nasrin
    Owens, Trevor
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 55 - 56
  • [40] Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination
    Prineas, John W.
    Parratt, John D. E.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (10): : 975 - 996